GLP-1 drugs are revolutionizing more than just waistlines, with nationwide usage doubling rapidly. These medications mimic the gut hormone glucagon-like peptide to signal fullness to the brain and slow gut motility. However, they often trigger GI side effects like nausea and vomiting, especially during dose changes.
GLP-1 drugs mimic a natural gut hormone called glucagon-like peptide (GLP). After meals, the stomach stretches and releases GLP, signaling the brain to stop eating.
"With GLP medications, they are the same molecules, stable over time," explained Khraishah. "So they kind of work on the brain to tell the brain, hey, you are full, but also work on the gut to slow down the gut motility."
Track your medication journey
Join thousands using Shotlee to track GLP-1 medications.
Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!
These mechanisms can lead to GI intolerance, a major issue for patients. Symptoms include nausea, vomiting, and diarrhea.
"The most common side effects of those medications are gut-related symptoms, and that goes back to how those medications work," Khraishah said. These effects are most frequent when starting treatment or adjusting doses, stemming from delayed gastric emptying in the GI tract.
Original source: WKYC 3 Cleveland
View original article →
Sciwind Biosciences has secured a landmark $495 million commercialization deal with Pfizer China for Ecnoglutide, a next-generation cAMP-biased GLP-1 receptor agonist. Approved for type 2 diabetes in China, it shows 15.1% placebo-adjusted weight loss in trials. This partnership aims to address rising obesity rates amid national health initiatives.
The UK Government has announced financial incentives for GPs to boost prescriptions of weight-loss injections Mounjaro and Wegovy on the NHS. Eight months into the mass rollout, not all practices are participating, prompting £25 million in funding for fairer access. Health Secretary Wes Streeting calls it a 'game changer' for obesity, but experts warn of workload risks.
Midlife weight gain is hitting millennial stars hard, but many are turning to Ozempic and other GLP-1s for help. Celebrities including Amy Schumer, Golnesa 'GG' Gharachedaghi, and Serena Williams have openly admitted to using these medications, sharing their triumphs, side effects, and transformations. Discover their stories and the science behind these popular drugs.
